Laurence Baillet

443 total citations
18 papers, 245 citations indexed

About

Laurence Baillet is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Laurence Baillet has authored 18 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Neurology. Recurrent topics in Laurence Baillet's work include Diet and metabolism studies (6 papers), Muscle metabolism and nutrition (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Laurence Baillet is often cited by papers focused on Diet and metabolism studies (6 papers), Muscle metabolism and nutrition (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Laurence Baillet collaborates with scholars based in France, United States and Belgium. Laurence Baillet's co-authors include Vincent Rigalleau, H. Gin, C. Perlemoine, V. Vergnot, Marie-Christine Beauvieux, Julie McGarry, Victoria Esser, Rashmi Mullur, Emmanuel Cuny and F. Macia and has published in prestigious journals such as Journal of Biological Chemistry, British Journal Of Nutrition and American Journal of Kidney Diseases.

In The Last Decade

Laurence Baillet

16 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Baillet France 10 66 60 53 48 42 18 245
E. M. Kohner United Kingdom 8 176 2.7× 38 0.6× 17 0.3× 27 0.6× 51 1.2× 12 350
I. R. Wallace United Kingdom 10 60 0.9× 47 0.8× 13 0.2× 13 0.3× 74 1.8× 26 299
Daniel Scarr Canada 12 140 2.1× 74 1.2× 42 0.8× 44 0.9× 34 0.8× 24 325
Alba Sulaj Germany 8 43 0.7× 75 1.3× 10 0.2× 24 0.5× 31 0.7× 24 180
Türkan Mete Türkiye 10 72 1.1× 100 1.7× 14 0.3× 27 0.6× 31 0.7× 22 261
David A. Price United States 13 39 0.6× 16 0.3× 32 0.6× 23 0.5× 43 1.0× 22 744
Lily Agrawal United States 11 160 2.4× 21 0.3× 35 0.7× 7 0.1× 56 1.3× 17 315
Masateru Katayama Japan 9 85 1.3× 58 1.0× 13 0.2× 33 0.7× 94 2.2× 20 339
Vojtech Pavlicek Switzerland 9 68 1.0× 28 0.5× 11 0.2× 44 0.9× 32 0.8× 24 307
Thomas McCorquodale Australia 6 60 0.9× 84 1.4× 11 0.2× 19 0.4× 87 2.1× 7 339

Countries citing papers authored by Laurence Baillet

Since Specialization
Citations

This map shows the geographic impact of Laurence Baillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Baillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Baillet more than expected).

Fields of papers citing papers by Laurence Baillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Baillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Baillet. The network helps show where Laurence Baillet may publish in the future.

Co-authorship network of co-authors of Laurence Baillet

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Baillet. A scholar is included among the top collaborators of Laurence Baillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Baillet. Laurence Baillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Perlemoine, C., F. Macia, François Tison, et al.. (2006). Subthalamic nucleus stimulation in parkinsonian patients does not increase serum ghrelin levels. 11.
2.
Perlemoine, C., F. Macia, François Tison, et al.. (2005). Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease. British Journal Of Nutrition. 93(2). 191–198. 43 indexed citations
3.
Rigalleau, Vincent, C. Lasseur, Philippe Chauveau, et al.. (2004). Resting energy expenditure in uremic, diabetic, and uremic diabetic subjects. Journal of Diabetes and its Complications. 18(4). 237–241. 14 indexed citations
4.
Gin, H., et al.. (2003). Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients. Diabetes & Metabolism. 29(5). 505–508. 14 indexed citations
5.
Rigalleau, Vincent, M. Beylot, Sylvie Normand, et al.. (2003). Mechanism of Increased Plasma Glucose Levels after Oral Glucose Ingestion in Normal-Weight Middle-Aged Subjects. Annals of Nutrition and Metabolism. 47(5). 186–193. 1 indexed citations
6.
Rigalleau, Vincent, Laurence Baillet, Catherine Lasseur, et al.. (2003). Splanchnic tissues play a crucial role in uremic glucose intolerance. Journal of Renal Nutrition. 13(3). 212–218. 5 indexed citations
7.
Viallard, Jean‐François, Patrick Blanco, D. Neau, et al.. (2003). Le déficit immunitaire commun variable de l’adulte : étude clinique, biologique et immunologique chez 17 patients. La Revue de Médecine Interne. 24(10). 640–650. 12 indexed citations
8.
Perlemoine, C., et al.. (2003). Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism. 52(10). 1258–1264. 37 indexed citations
9.
Gin, H., Vincent Rigalleau, & Laurence Baillet. (2003). [Diet and physical activity in type 2 diabetes prevention].. PubMed. 53(10). 1074–7. 5 indexed citations
10.
Gin, H., et al.. (2002). Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.. PubMed. 28(6 Pt 1). 457–61. 28 indexed citations
11.
Rigalleau, Vincent, Laurence Baillet, Mélèze Hocini, & H. Gin. (2002). Atrial fibrillation can cause major hyperglycemia.. PubMed. 28(3). 239–40. 5 indexed citations
13.
Précigout, V. de, Philippe Chauveau, Waël El Haggan, et al.. (2000). No change of hyperleptinemia despite a decrease in insulin concentration in patients with chronic renal failure on a supplemented very low protein diet. American Journal of Kidney Diseases. 36(6). 1201–1206. 13 indexed citations
14.
Baillet, Laurence, Rashmi Mullur, Victoria Esser, & Julie McGarry. (2000). Elucidation of the Mechanism by Which (+)-Acylcarnitines Inhibit Mitochondrial Fatty Acid Transport. Journal of Biological Chemistry. 275(47). 36766–36768. 21 indexed citations
15.
Baillet, Laurence, Jacques Epelbaum, Albert Beckers, et al.. (1999). Expression of somatostatin receptor subtypes 2 and 5 in human prolactinomas. Open Repository and Bibliography (University of Liège). 1 indexed citations
16.
Schaeverbeke, T., et al.. (1999). Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case.. PubMed. 66(3). 177–9. 11 indexed citations
17.
Rigalleau, Vincent, et al.. (1999). Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study.. PubMed. 25(4). 321–8. 23 indexed citations
18.
Rigalleau, Vincent, et al.. (1998). Erythropoietin can deteriorate glucose control in uraemic non-insulin-dependent diabetic patients.. PubMed. 24(1). 62–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026